Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting

M. Ladetto, S. Sametti, M. Astolfi, P. Corradini, I. Ricca, D. Drandi, A. Pileri, C. Tarella

Research output: Contribution to journalArticlepeer-review

Abstract

Although molecular remissions have been frequently observed and associated with low likelihood of relapse in some lymphoid tumours, they are seldom reported in mantle cell lymphoma (MCL). We performed PCR analysis of a MCL patient with central nervous system (CNS) relapse occurring 76 months after autologous transplantation. Molecular follow-up showed constant absence of PCR-detectable disease, even after the onset of relapse. These data indicate that isolated CNS relapse may occur even after several years of continuous remission and cannot be excluded based on a persistent pattern of molecular remission. However, the prolonged remission duration observed in this patient suggests that achieving PCR-negativity may also be of benefit for MCL patients.

Original languageEnglish
Pages (from-to)679-682
Number of pages4
JournalLeukemia and Lymphoma
Volume40
Issue number5-6
Publication statusPublished - 2001

Keywords

  • Central nervous system relapse
  • Immunoglobulin genes
  • Mantle cell lymphoma
  • Minimal residual disease

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting'. Together they form a unique fingerprint.

Cite this